Us Bancorp \De\ Ligand Pharmaceuticals Inc Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 758 shares of LGND stock, worth $81,977. This represents 0.0% of its overall portfolio holdings.

Number of Shares

758

Previous 660 14.85%

Holding current value

$81,977

Previous $66,000 22.73%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$99.95 - $129.9 $9,795 - $12,730	98 Added 14.85%	758 $81,000
Q3 2024 Oct 28, 2024	BUY	$82.7 - $110.11 $992 - $1,321	12 Added 1.85%	660 $66,000
Q2 2024 Aug 06, 2024	SELL	$68.53 - $87.91 $822 - $1,054	-12 Reduced 1.82%	648 $54,000
Q1 2024 May 07, 2024	BUY	$68.64 - $89.2 $3,294 - $4,281	48 Added 7.84%	660 $48,000
Q4 2023 Feb 09, 2024	BUY	$49.57 - $72.63 $26,321 - $38,566	531 Added 655.56%	612 $43,000
Q3 2023 Nov 03, 2023	SELL	$58.86 - $72.67 $11,418 - $14,097	-194 Reduced 70.55%	81 $4,000
Q2 2023 Aug 09, 2023	SELL	$69.53 - $79.33 $417 - $475	-6 Reduced 2.14%	275 $19,000
Q1 2023 May 09, 2023	BUY	$65.67 - $77.08 $16,089 - $18,884	245 Added 680.56%	281 $20,000
Q4 2022 Feb 13, 2023	SELL	$61.72 - $96.74 $987 - $1,547	-16 Reduced 30.77%	36 $2,000
Q3 2022 Oct 27, 2022	SELL	$0.01 - $107.56 $0 - $1,398	-13 Reduced 20.0%	52 $5,000
Q2 2022 Aug 01, 2022	SELL	$74.52 - $117.06 $596 - $936	-8 Reduced 10.96%	65 $6,000
Q1 2022 May 11, 2022	SELL	$94.99 - $151.56 $22,702 - $36,222	-239 Reduced 76.6%	73 $8,000
Q4 2021 Feb 11, 2022	BUY	$127.69 - $165.85 $5,618 - $7,297	44 Added 16.42%	312 $48,000
Q3 2021 Nov 10, 2021	SELL	$102.33 - $144.73 $61,398 - $86,838	-600 Reduced 69.12%	268 $38,000
Q2 2021 Aug 05, 2021	SELL	$113.03 - $155.64 $5,312 - $7,315	-47 Reduced 5.14%	868 $114,000
Q1 2021 Apr 28, 2021	BUY	$99.52 - $215.83 $58,617 - $127,123	589 Added 180.67%	915 $140,000
Q4 2020 Feb 04, 2021	SELL	$80.55 - $106.05 $75,153 - $98,944	-933 Reduced 74.11%	326 $32,000
Q3 2020 Nov 10, 2020	SELL	$89.56 - $126.72 $4,030 - $5,702	-45 Reduced 3.45%	1,259 $120,000
Q2 2020 Aug 07, 2020	SELL	$68.28 - $123.65 $41,377 - $74,931	-606 Reduced 31.73%	1,304 $146,000
Q1 2020 May 13, 2020	SELL	$63.37 - $107.88 $3,802 - $6,472	-60 Reduced 3.05%	1,910 $139,000
Q4 2019 Feb 04, 2020	SELL	$96.94 - $113.59 $28,403 - $33,281	-293 Reduced 12.95%	1,970 $206,000
Q3 2019 Nov 08, 2019	SELL	$86.25 - $120.16 $82,455 - $114,872	-956 Reduced 29.7%	2,263 $225,000
Q2 2019 Aug 13, 2019	SELL	$107.38 - $129.34 $24,160 - $29,101	-225 Reduced 6.53%	3,219 $367,000
Q1 2019 May 08, 2019	SELL	$105.93 - $142.47 $690,875 - $929,189	-6,522 Reduced 65.44%	3,444 $433,000
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $274,048 - $580,997	2,135 Added 27.26%	9,966 $1.35 Million
Q3 2018 Nov 01, 2018	SELL	$211.18 - $274.49 $696,682 - $905,542	-3,299 Reduced 29.64%	7,831 $2.15 Million
Q2 2018 Aug 08, 2018	BUY	$150.77 - $207.98 $138,105 - $190,509	916 Added 8.97%	11,130 $2.31 Million
Q1 2018 May 08, 2018	SELL	$138.63 - $182.62 $105,913 - $139,521	-764 Reduced 6.96%	10,214 $1.69 Million
Q4 2017 Feb 02, 2018	BUY	$128.36 - $147.04 $314,096 - $359,806	2,447 Added 28.68%	10,978 $1.5 Million
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $1.03 Million - $1.18 Million	8,531	8,531 $1.16 Million

Others Institutions Holding LGND

# of Institutions

277

Shares Held

18.5M

Call Options Held

30.8K

Put Options Held

5.2K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.83B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account